Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hyperosmolar Priming Solution for Cardiopulmonary Bypass
NCT05914896Completed
- Sponsor
- Umeå University
- Start
- Apr 2019
- Primary completion
- Jun 2020
- Modality
- Inhalation Devices, Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of Bronchitol and sodium chloride in cardiopulmonary bypass (CPB) (2 arms), sponsored by Umeå University. Primary endpoint: Postoperative Acute Kidney Injury at 3 days. Started Apr 2019; status: completed.
02
Drugs
Bronchitolsodium chloride
03
Conditions
cardiopulmonary bypass (CPB)
Beyond the preview
Go deeper on NCT05914896.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05914896.